Utility of Salivary Biomarkers for Demonstrating Acute Myocardial Infarction
暂无分享,去创建一个
Craig S. Miller | J. McDevitt | R. Kryscio | J. Ebersole | Xiuhua Ding | P. Floriano | M. J. Novak | D. Kinane | N. Christodoulides | C S Miller | R J Kryscio | J L Ebersole | C. Campbell | N Christodoulides | J T McDevitt | J D Foley | P N Floriano | C L Campbell | A L Bailey | B G Rose | D F Kinane | M J Novak | X Ding | J. D. Foley | A. Bailey | B. Rose | X. Ding | C.S. Miller | M. J. Novak | B.G. Rose | Craig S. Miller | J. Ebersole
[1] G. Lamas,et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.
[2] P. Vokonas,et al. A comparison of the Framingham and European Society of Cardiology coronary heart disease risk prediction models in the normative aging study. , 2002, American heart journal.
[3] Nader Rifai,et al. Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes: Simultaneous Assessment of Troponin I, C-Reactive Protein, and B-Type Natriuretic Peptide , 2002, Circulation.
[4] David A Morrow,et al. Future of Biomarkers in Acute Coronary Syndromes Moving Toward a Multimarker Strategy , 2003, Circulation.
[5] John T McDevitt,et al. Current developments in salivary diagnostics. , 2010, Biomarkers in medicine.
[6] Sarah L Cutrona,et al. Waits to see an emergency department physician: U.S. trends and predictors, 1997-2004. , 2008, Health affairs.
[7] Craig S. Miller,et al. Oral fluids that detect cardiovascular disease biomarkers. , 2012, Oral surgery, oral medicine, oral pathology and oral radiology.
[8] I. Mirzaii-Dizgah,et al. Unstimulated whole saliva creatine phosphokinase in acute myocardial infarction. , 2011, Oral diseases.
[9] W. Gibler,et al. Discordant cardiac biomarkers: frequency and outcomes in emergency department patients with chest pain. , 2006, Annals of emergency medicine.
[10] K. Blick,et al. A rapid point-of-care cardiac marker testing strategy facilitates the rapid diagnosis and management of chest pain patients in the emergency department. , 2008, American journal of clinical pathology.
[11] M. Busby,et al. Evaluation of an oral health scoring system by dentists in general dental practice , 2003, British Dental Journal.
[12] Harlan M Krumholz,et al. Implementation and integration of prehospital ECGs into systems of care for acute coronary syndrome: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research, Emergency Cardiovascular Care Committee, Council on Cardiovascular Nursi , 2008, Circulation.
[13] A. Aribas,et al. Serum and Saliva Levels of Ischemia‐Modified Albumin in Patients with Acute Myocardial Infarction , 2013, Journal of clinical laboratory analysis.
[14] D. Mozaffarian,et al. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.
[15] D. T. Wong,et al. Large‐scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two‐dimensional gel electrophoresis‐mass spectrometry , 2005, Proteomics.
[16] Timo Sorsa,et al. Acute myocardial infarction is reflected in salivary matrix metalloproteinase-8 activation level. , 2011, Journal of periodontology.
[17] M. Bissell,et al. Use of Saliva-Based Nano-Biochip Tests for Acute Myocardial Infarction at the Point of Care: A Feasibility Study , 2011 .
[18] I. Mirzaii-Dizgah,et al. Salivary high-sensitivity cardiac troponin T levels in patients with acute myocardial infarction. , 2013, Oral diseases.
[19] Alan H B Wu,et al. Early detection of acute coronary syndromes and risk stratification by multimarker analysis. , 2007, Biomarkers in medicine.
[20] Yue-Cune Chang,et al. Diagnostic performance of initial salivary alpha-amylase activity for acute myocardial infarction in patients with acute chest pain. , 2012, The Journal of emergency medicine.
[21] H. Zoellner,et al. Dental Infection and Vascular Disease , 2011, Seminars in thrombosis and hemostasis.
[22] W. Gibler,et al. Door-to-ECG time in patients with chest pain presenting to the ED. , 2006, The American journal of emergency medicine.
[23] Talicia Tarver,et al. HEART DISEASE AND STROKE STATISTICS–2014 UPDATE: A REPORT FROM THE AMERICAN HEART ASSOCIATION , 2014 .
[24] G. Schuler,et al. ST-segment resolution and prognosis after facilitated versus primary percutaneous coronary intervention in acute myocardial infarction: a meta-analysis , 2009, Clinical Research in Cardiology.
[25] I. Mirzaii-Dizgah,et al. Salivary troponin I as an indicator of myocardial infarction , 2013, The Indian journal of medical research.
[26] John T McDevitt,et al. Salivary biomarkers associated with myocardial necrosis: results from an alcohol septal ablation model. , 2012, Oral surgery, oral medicine, oral pathology and oral radiology.
[27] M. O’Donoghue,et al. Biomarkers in ACS and heart failure: should men and women be interpreted differently? , 2014, Clinical chemistry.
[28] Hua Xiao,et al. Proteomics and its applications for biomarker discovery in human saliva , 2011, Bioinformation.
[29] I. Mirzaii-Dizgah,et al. Saliva-based creatine kinase MB measurement as a potential point-of-care testing for detection of myocardial infarction , 2012, Clinical Oral Investigations.
[30] E. Antman,et al. Development of Systems of Care for ST-Elevation Myocardial Infarction Patients , 2007 .
[31] D. Dudek,et al. Impact of time-to-treatment on myocardial perfusion after primary percutaneous coronary intervention with Gp IIb–IIIa inhibitors , 2013, Journal of cardiovascular medicine.
[32] John S Rumsfeld,et al. Door-to-balloon time and mortality among patients undergoing primary PCI. , 2013, The New England journal of medicine.